Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Breast Cancer Res Treat · 2024 · PMC11101536 · PMID 38273214

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

While a numerical trend in favoring prolonged ET for patients with a higher CTS5 was found, a significantly predictive value for the score could not be confirmed.

also in 337 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.